Ligand profile
OR4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1426 — DSBA-like thioredoxin domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
OR4- PDB
6pml- UniProt (similar protein)
P0AEG4- Target protein
- VK055_1426
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 59.7
- −1 ≤ LogP ≤ 5 3.64
- MW ≤ 500 Da 282.3
- LogP ≤ 5 3.64
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 59.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)COc2ccc3c(c2)occ3CC(=O)Oc1ccc(cc1)COc2ccc3c(c2)occ3CC(=O)O
InChI=1S/C17H14O4/c18-17(19)8-13-11-21-16-9-14(6-7-15(13)16)20-10-12-4-2-1-3-5-12/h1-7,9,11H,8,10H2,(H,18,19)InChI=1S/C17H14O4/c18-17(19)8-13-11-21-16-9-14(6-7-15(13)16)20-10-12-4-2-1-3-5-12/h1-7,9,11H,8,10H2,(H,18,19)
VJEZHKLENQLLAZ-UHFFFAOYSA-NVJEZHKLENQLLAZ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01323
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand OR4 →
- PDB RCSB structure 6pml →
- UniProt UniProt P0AEG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “OR4”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1426.
PDB 25
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 11
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).